(CNN) -- Merck said Monday it is seeking FDA emergency use authorization for its experimental antiviral COVID-19 treatment, molnupiravir. If authorization is granted, the drug, made by Merck and Ridgeback Biotherapeutics, would be the first oral antiviral treatment to fight Covid-19.